Viking Global Equities II LP
Insider CIK 1413378 · ABUS 10% owner · ADPT 10% owner · W 10% owner · ROIV 10% owner · AXON 10% owner · EDIT 10% owner · MYOV 10% owner · UROV 10% owner · API 10% owner · FDC 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APG APi Group Corp | S Sale | 2024-06-17 | 2024-06-18 | 39,032 | $38.15 | $1.49M | 0 | SEC↗ |
| APG APi Group Corp | S Sale | 2024-06-17 | 2024-06-18 | 1,912,750 | $38.15 | $72.97M | 0 | SEC↗ |
| APG APi Group Corp | S Sale | 2024-03-05 | 2024-03-07 | 60,772 | $34.25 | $2.08M | 39,032 | SEC↗ |
| APG APi Group Corp | S Sale | 2024-03-05 | 2024-03-07 | 2,977,845 | $34.25 | $101.99M | 1,912,750 | SEC↗ |
| APG APi Group Corp | C Conversion deriv | 2024-02-28 | 2024-03-01 | 196,000 | — | $0 | 0 | SEC↗ |
| APG APi Group Corp | C Conversion deriv | 2024-02-28 | 2024-03-01 | 4,000 | — | $0 | 0 | SEC↗ |
| APG APi Group Corp | J Other | 2024-02-28 | 2024-03-01 | 3,983,739 | $36.90 | $147.00M | 4,890,595 | SEC↗ |
| APG APi Group Corp | C Conversion | 2024-02-28 | 2024-03-01 | 8,036,862 | $24.60 | $197.71M | 8,874,334 | SEC↗ |
| APG APi Group Corp | C Conversion | 2024-02-28 | 2024-03-01 | 164,016 | $24.60 | $4.03M | 181,104 | SEC↗ |
| APG APi Group Corp | J Other | 2024-02-28 | 2024-03-01 | 81,300 | $36.90 | $3.00M | 99,804 | SEC↗ |
| APG APi Group Corp | S Sale | 2024-01-02 | 2024-01-04 | 195,200 | $31.30 | $6.11M | 837,472 | SEC↗ |
| APG APi Group Corp | S Sale | 2024-01-02 | 2024-01-04 | 6,300,817 | $31.30 | $197.22M | 27,032,516 | SEC↗ |
| APG APi Group Corp | S Sale | 2024-01-02 | 2024-01-04 | 3,983 | $31.30 | $124.7K | 17,088 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2023-06-22 | 2023-06-26 | 110,756 | $9.90 | $1.10M | 641,010 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2023-06-22 | 2023-06-26 | 5,427,043 | $9.90 | $53.73M | 31,409,512 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2023-06-22 | 2023-06-26 | 5,236,006 | $9.90 | $51.84M | 30,303,871 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2023-06-22 | 2023-06-26 | 2,226,195 | $9.90 | $22.04M | 12,884,307 | SEC↗ |
| API APi Group Corp | P Buy deriv | 2022-01-03 | 2022-01-05 | 196,000 | $1000.00 | $196.00M | 196,000 | SEC↗ |
| API APi Group Corp | P Buy deriv | 2022-01-03 | 2022-01-05 | 4,000 | $1000.00 | $4.00M | 4,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-12-14 | 2020-12-16 | 1,000,000 | $55.65 | $55.65M | 29,993,708 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-11-11 | 2020-11-13 | 2,500,000 | $49.52 | $123.80M | 30,993,708 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-01-28 | 2020-01-30 | 4,912,899 | $24.98 | $122.72M | 33,493,708 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-19 | 2019-06-19 | 4,957 | $8.17 | $40.5K | 22,860,013 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-18 | 2019-06-19 | 6,706 | $8.21 | $55.1K | 22,855,056 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-17 | 2019-06-19 | 6,541 | $8.53 | $55.8K | 22,848,350 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-14 | 2019-06-14 | 7,144 | $7.91 | $56.5K | 22,841,809 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-13 | 2019-06-14 | 7,367 | $7.95 | $58.6K | 22,834,665 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-12 | 2019-06-14 | 7,500 | $8.30 | $62.3K | 22,827,298 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-11 | 2019-06-11 | 7,189 | $8.58 | $61.7K | 22,819,798 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-10 | 2019-06-11 | 7,500 | $8.35 | $62.6K | 22,812,609 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-07 | 2019-06-11 | 6,649 | $7.97 | $53.0K | 22,805,109 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-06 | 2019-06-06 | 7,082 | $8.00 | $56.7K | 22,798,460 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-05 | 2019-06-06 | 6,540 | $8.02 | $52.5K | 22,791,378 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-04 | 2019-06-06 | 7,500 | $7.59 | $56.9K | 22,784,838 | SEC↗ |
| MYOV Myovant Sciences Ltd. | P Buy | 2019-06-04 | 2019-06-13 | 2,424,242 | $8.25 | $20.00M | 40,765,599 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-06-03 | 2019-06-03 | 5,424 | $7.71 | $41.8K | 22,777,338 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-31 | 2019-06-03 | 5,071 | $7.70 | $39.0K | 22,771,914 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-30 | 2019-06-03 | 300 | $8.91 | $2.7K | 22,766,843 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-30 | 2019-06-03 | 6,951 | $7.97 | $55.4K | 22,766,543 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-29 | 2019-05-29 | 6,882 | $7.55 | $52.0K | 22,759,592 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-28 | 2019-05-29 | 3,807 | $7.68 | $29.2K | 22,752,710 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-24 | 2019-05-29 | 3,796 | $7.70 | $29.2K | 22,748,903 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-23 | 2019-05-23 | 4,802 | $7.76 | $37.3K | 22,745,107 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-22 | 2019-05-23 | 5,033 | $8.06 | $40.6K | 22,740,305 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-21 | 2019-05-23 | 9,995 | $8.52 | $85.2K | 22,735,272 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-20 | 2019-05-20 | 8,285 | $7.98 | $66.1K | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-20 | 2019-05-20 | 1,715 | $8.39 | $14.4K | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-17 | 2019-05-20 | 6,200 | $7.36 | $45.6K | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2019-05-16 | 2019-05-20 | 5,408 | $6.79 | $36.7K | 22,709,077 | SEC↗ |
| AXON Axovant Sciences Ltd. | P Buy | 2019-03-18 | 2019-03-19 | 6,666,667 | $1.50 | $10.00M | 105,952,381 | SEC↗ |
| AXON Axovant Sciences Ltd. | P Buy | 2018-12-18 | 2018-12-20 | 10,000,000 | $1.00 | $10.00M | 99,285,714 | SEC↗ |
| UROV Urovant Sciences Ltd. | P Buy | 2018-10-01 | 2018-10-03 | 2,678,571 | $14.00 | $37.50M | 22,703,669 | SEC↗ |
| AXON Axovant Sciences Ltd. | P Buy | 2018-06-05 | 2018-06-07 | 14,285,714 | $1.75 | $25.00M | 89,285,714 | SEC↗ |
| MYOV Myovant Sciences Ltd. | P Buy | 2018-04-02 | 2018-04-04 | 1,110,015 | $20.27 | $22.50M | 38,341,357 | SEC↗ |
| ABUS Arbutus Biopharma Corp | P Buy deriv | 2018-01-12 | 2018-01-16 | 664,000 | $100.00 | $66.40M | 1,164,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | P Buy deriv | 2017-10-16 | 2017-10-17 | 500,000 | $100.00 | $50.00M | 500,000 | SEC↗ |
| FDC FIRST DATA CORP | C Conversion deriv | 2016-04-13 | 2016-04-15 | 10,144,738 | — | $0 | 0 | SEC↗ |
| FDC FIRST DATA CORP | C Conversion deriv | 2016-04-13 | 2016-04-15 | 21,750,064 | — | $0 | 0 | SEC↗ |
| FDC FIRST DATA CORP | C Conversion deriv | 2016-04-13 | 2016-04-15 | 5,413,702 | — | $0 | 0 | SEC↗ |
| FDC FIRST DATA CORP | C Conversion deriv | 2016-04-13 | 2016-04-15 | 317,519 | — | $0 | 0 | SEC↗ |
| FDC FIRST DATA CORP | C Conversion deriv | 2016-04-13 | 2016-04-15 | 5,874,105 | — | $0 | 0 | SEC↗ |
| FDC FIRST DATA CORP | C Conversion | 2016-04-13 | 2016-04-15 | 10,144,738 | — | $0 | 10,144,738 | SEC↗ |
| FDC FIRST DATA CORP | C Conversion | 2016-04-13 | 2016-04-15 | 5,874,105 | — | $0 | 5,874,105 | SEC↗ |
| FDC FIRST DATA CORP | C Conversion | 2016-04-13 | 2016-04-15 | 317,519 | — | $0 | 317,519 | SEC↗ |
| FDC FIRST DATA CORP | C Conversion | 2016-04-13 | 2016-04-15 | 5,413,702 | — | $0 | 5,413,702 | SEC↗ |
| FDC FIRST DATA CORP | C Conversion | 2016-04-13 | 2016-04-15 | 21,750,064 | — | $0 | 21,750,064 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-08 | 4,444,444 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-08 | 4,444,444 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-09 | 4,444,444 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion deriv | 2016-02-08 | 2016-02-09 | 4,444,444 | — | $0 | 0 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion | 2015-02-08 | 2016-02-08 | 1,709,401 | — | $0 | 1,709,401 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-08 | 5,335 | — | $0 | 266,782 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-08 | 256,986 | — | $0 | 256,986 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-08 | 20,407 | — | $0 | 2,729,808 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion | 2015-02-08 | 2016-02-08 | 1,709,401 | — | $0 | 1,709,401 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-08 | 1,000,000 | — | $0 | 2,709,401 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-08 | 261,447 | — | $0 | 261,447 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-08 | 15,072 | — | $0 | 15,072 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-08 | 481,567 | — | $0 | 481,567 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-09 | 5,335 | — | $0 | 266,782 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-09 | 1,000,000 | — | $0 | 2,709,401 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-09 | 20,407 | — | $0 | 2,729,808 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion | 2015-02-08 | 2016-02-09 | 1,709,401 | — | $0 | 1,709,401 | SEC↗ |
| EDIT Editas Medicine, Inc. | C Conversion | 2015-02-08 | 2016-02-09 | 1,709,401 | — | $0 | 1,709,401 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-09 | 261,447 | — | $0 | 261,447 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-09 | 481,567 | — | $0 | 481,567 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-09 | 15,072 | — | $0 | 15,072 | SEC↗ |
| EDIT Editas Medicine, Inc. | P Buy | 2015-02-08 | 2016-02-09 | 256,986 | — | $0 | 256,986 | SEC↗ |
| W Wayfair Inc. | P Buy | 2014-10-02 | 2014-10-06 | 79,250 | — | $0 | 1,750,236 | SEC↗ |
| W Wayfair Inc. | P Buy | 2014-10-02 | 2014-10-06 | 400,000 | — | $0 | 1,750,236 | SEC↗ |
| W Wayfair Inc. | P Buy | 2014-10-02 | 2014-10-06 | 5,840 | — | $0 | 25,054 | SEC↗ |
| W Wayfair Inc. | P Buy | 2014-10-02 | 2014-10-06 | 99,621 | — | $0 | 427,215 | SEC↗ |